Boston Scientific ROE 2006-2018 | BSX

Current and historical return on equity (ROE) values for Boston Scientific (BSX) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Boston Scientific ROE for the three months ending September 30, 2018 was 26.44%.
Boston Scientific ROE - Return on Equity Historical Data
Date TTM Net Income Shareholder's Equity Return on Equity
2018-09-30 $0.67B $8.29B 8.91%
2018-06-30 $0.52B $7.74B 7.09%
2018-03-31 $0.11B $7.03B 1.55%
2017-12-31 $0.10B $7.01B 1.44%
2017-09-30 $0.84B $7.59B 11.79%
2017-06-30 $0.79B $7.24B 11.46%
2017-03-31 $0.44B $7.05B 6.57%
2016-12-31 $0.35B $6.73B 5.36%
2016-09-30 $0.08B $6.48B 1.27%
2016-06-30 $-0.35B $6.22B -5.43%
2016-03-31 $-0.04B $6.46B -0.56%
2015-12-31 $-0.24B $6.32B -3.70%
2015-09-30 $-0.40B $6.41B -6.10%
2015-06-30 $-0.16B $6.58B -2.36%
2015-03-31 $-0.25B $6.50B -3.86%
2014-12-31 $-0.12B $6.46B -1.81%
2014-09-30 $0.29B $6.70B 4.38%
2014-06-30 $0.24B $6.54B 3.67%
2014-03-31 $0.37B $6.53B 5.58%
2013-12-31 $-0.12B $6.54B -1.85%
2013-09-30 $-0.17B $6.56B -2.53%
2013-06-30 $-0.83B $6.60B -12.34%
2013-03-31 $-4.54B $6.50B -64.95%
2012-12-31 $-4.07B $6.87B -49.58%
2012-09-30 $-4.02B $6.83B -43.13%
2012-06-30 $-3.22B $7.73B -30.63%
2012-03-31 $0.51B $11.40B 4.44%
2011-12-31 $0.44B $11.35B 3.85%
2011-09-30 $0.57B $11.52B 4.99%
2011-06-30 $0.62B $11.54B 5.46%
2011-03-31 $0.57B $11.37B 5.11%
2010-12-31 $-1.07B $11.30B -9.68%
2010-09-30 $-2.38B $11.04B -21.12%
2010-06-30 $-2.66B $10.89B -22.52%
2010-03-31 $-2.60B $10.78B -20.89%
2009-12-31 $-1.03B $12.30B -7.84%
2009-09-30 $-2.33B $13.30B -17.54%
2009-06-30 $-2.31B $13.41B -16.64%
2009-03-31 $-2.37B $13.28B -16.42%
2008-12-31 $-2.04B $13.17B -13.60%
2008-09-30 $-0.11B $15.69B -0.72%
2008-06-30 $-0.31B $15.64B -2.01%
2008-03-31 $-0.29B $15.39B -1.90%
2007-12-31 $-0.50B $15.10B -3.20%
2007-09-30 $0.24B $15.52B 1.54%
2007-06-30 $0.59B $15.80B 3.81%
2007-03-31 $-3.79B $15.55B -24.95%
2006-12-31 $-3.58B $15.30B -28.69%
2006-09-30 $-3.52B $15.02B -36.24%
2006-06-30 $-3.87B $14.89B -55.73%
2006-03-31 $0.60B $4.67B 14.11%
2005-12-31 $0.63B $4.28B 14.96%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $50.107B $9.048B
Boston Scientific Corporation transforms lives through innovative medical solutions that improve the health of patients around the world. As a global medical technology leader they advance science for life by providing a broad range of high performance solutions that address unmet patient needs and reduce the cost of healthcare.
Stock Name Country Market Cap PE Ratio
Medtronic (MDT) Ireland $124.396B 19.07
Abbott Laboratories (ABT) United States $121.907B 24.70
Stryker (SYK) United States $62.115B 23.41
Baxter (BAX) United States $33.967B 21.93
Zimmer Biomet Holdings (ZBH) United States $22.913B 14.86
Smith & Nephew SNATS (SNN) United Kingdom $16.016B 0.00
ResMed (RMD) United States $14.484B 27.62
Perrigo (PRGO) Ireland $8.621B 13.09
Bio-Rad Laboratories (BIO) United States $8.038B 51.40
Canopy Growth (CGC) Canada $7.963B 0.00
Hill-Rom Holdings (HRC) United States $6.061B 19.22
Aurora Cannabis (ACB) Canada $5.941B 32.42
Haemonetics (HAE) United States $5.495B 48.32
Hutchison China MediTech (HCM) China $5.011B 0.00
Insulet (PODD) United States $4.690B 0.00
ICU Medical (ICUI) United States $4.600B 25.63
GW Pharmaceuticals (GWPH) United Kingdom $3.898B 0.00
Agios Pharmaceuticals (AGIO) United States $3.709B 0.00
National Vision Holdings (EYE) United States $3.224B 62.36
Neogen (NEOG) United States $3.190B 48.31
NuVasive (NUVA) United States $3.045B 28.33
Quidel (QDEL) United States $2.390B 31.16
Aphria (APHA) $2.383B 0.00
NxStage Medical (NXTM) United States $1.935B 0.00
Phibro Animal Health (PAHC) United States $1.455B 20.60
AtriCure (ATRC) United States $1.189B 0.00
Cardiovascular Systems (CSII) United States $1.007B 1450.50
VAREX IMAGING (VREX) United States $0.933B 18.74
Meridian Bioscience (VIVO) United States $0.816B 26.01
Surmodics (SRDX) United States $0.775B 118.39
OraSure Technologies (OSUR) United States $0.771B 43.38
Eagle Pharmaceuticals (EGRX) United States $0.738B 23.67
PetIQ (PETQ) United States $0.737B 20.93
MacroGenics (MGNX) United States $0.702B 0.00
Cerus (CERS) United States $0.685B 0.00
Lantheus Holdings (LNTH) United States $0.604B 18.68
Omeros (OMER) United States $0.569B 0.00
Owens & Minor (OMI) United States $0.550B 6.22
Insys Therapeutics (INSY) United States $0.531B 0.00
LeMaitre Vascular (LMAT) United States $0.510B 25.05
NanoString Technologies (NSTG) United States $0.478B 0.00
TG Therapeutics (TGTX) United States $0.429B 0.00
Evolus (EOLS) United States $0.373B 0.00
Quanterix (QTRX) United States $0.361B 0.00
Utah Medical Products (UTMD) United States $0.326B 21.11
Cytosorbents (CTSO) United States $0.287B 0.00
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.254B 0.00
Rockwell Medical (RMTI) United States $0.230B 0.00
Surface Oncology (SURF) United States $0.218B 0.00
BioLife Solutions (BLFS) United States $0.197B 265.75
Bovie Medical (BVX) United States $0.189B 0.00
Chimerix (CMRX) United States $0.168B 0.00
Fonar (FONR) United States $0.141B 7.07
Conatus Pharmaceuticals (CNAT) United States $0.138B 0.00
Imprimis Pharmaceuticals (IMMY) United States $0.107B 0.00
Chembio Diagnostics (CEMI) United States $0.099B 0.00
United-Guardian (UG) United States $0.080B 16.85
Female Health (VERU) United States $0.077B 0.00
Oramed Pharmaceuticals (ORMP) Israel $0.071B 0.00
Trinity Biotech (TRIB) Ireland $0.068B 21.53
InfuSystems Holdings (INFU) United States $0.067B 0.00
CAS Medical Systems (CASM) United States $0.053B 0.00
Neurotrope (NTRP) United States $0.047B 0.00
ImmuCell (ICCC) United States $0.041B 0.00
Capricor Therapeutics (CAPR) United States $0.027B 0.00
Myomo (MYO) United States $0.024B 0.00
InVivo Therapeutics Holdings (NVIV) United States $0.018B 0.00
Valeritas Holdings (VLRX) United States $0.017B 0.00
Senestech (SNES) United States $0.017B 0.00
Cellectar Biosciences (CLRB) United States $0.011B 0.00
NeuroMetrix (NURO) United States $0.007B 0.00
Akers Biosciences Inc (AKER) United States $0.000B 0.00